Citius Pharma investors elect board, back auditor
Citius Pharmaceuticals, Inc. reported results from its 2026 Annual Meeting of stockholders.
Rhea-AI Filing Summary
Citius Pharmaceuticals, Inc. reported results from its 2026 Annual Meeting of stockholders. Shareholders elected seven directors, including Leonard Mazur and Myron Holubiak, to one-year terms ending at the 2027 annual meeting or until successors are elected and qualified.
Stockholders also ratified Wolf & Company, P.C. as the independent registered public accounting firm for the fiscal year ending September 30, 2026, with 8,593,946 shares voting for, 855,866 against and 673,867 abstaining, and no broker non-votes reported on this item.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Votes for Leonard Mazur: 2,391,069 shares for
Votes withheld for Leonard Mazur: 1,071,618 shares withheld
Broker non-votes on director items: 6,660,992 broker non-votes
+3 more
6 metrics
Votes for Leonard Mazur
2,391,069 shares for
Director election at 2026 Annual Meeting
Votes withheld for Leonard Mazur
1,071,618 shares withheld
Director election at 2026 Annual Meeting
Broker non-votes on director items
6,660,992 broker non-votes
Each director election proposal
Votes for auditor ratification
8,593,946 shares for
Ratification of Wolf & Company, P.C.
Votes against auditor ratification
855,866 shares against
Ratification of Wolf & Company, P.C.
Abstentions on auditor ratification
673,867 shares abstaining
Ratification of Wolf & Company, P.C.
Key Terms
Annual Meeting of stockholders, broker non-votes, independent registered public accounting firm, fiscal year ending September 30, 2026
4 terms
Annual Meeting of stockholders financial
"held our 2026 annual meeting of stockholders (the “Annual Meeting”)"
broker non-votes financial
"Broker Non-Votes | ... | 6,660,992"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
independent registered public accounting firm financial
"ratified the selection of Wolf & Company, P.C. as our independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
fiscal year ending September 30, 2026 financial
"for the fiscal year ending September 30, 2026"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Which directors were elected to the Citius Pharmaceuticals (CTXR) board in 2026?
Shareholders elected Leonard Mazur, Myron Holubiak, Suren Dutia, Dr. Eugene Holuka, Dennis M. McGrath, Robert Smith and Carol Webb to the board, each for a one-year term expiring at the 2027 annual meeting or until a successor is duly elected and qualified.
Who is the independent registered public accounting firm for Citius Pharmaceuticals (CTXR) in fiscal 2026?
Wolf & Company, P.C. serves as the independent registered public accounting firm for the fiscal year ending September 30, 2026, after shareholders ratified its selection at the 2026 Annual Meeting by a wide margin of votes cast in favor of the proposal.
What were the vote totals for Citius Pharmaceuticals (CTXR) director Leonard Mazur?
For director nominee Leonard Mazur, shareholders cast 2,391,069 shares for his election, 1,071,618 shares withheld, and 6,660,992 broker non-votes, resulting in his election to the board for a one-year term ending at the 2027 annual meeting.
AI-generated analysis. How Rhea-AI works. Not financial advice.
